{"DataElement":{"publicId":"5701687","version":"2","preferredName":"Personal Medical History Negation Prior Breast Carcinoma Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time the patient does not have a previous history of breast cancer, as outlined in the study protocol, in order to participate in a clinical study.","longName":"NGN_HX_BR_CA_CONF","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"5701686","version":"1","preferredName":"Personal Medical History Negation Prior Breast Carcinoma Confirmation Clinical Trial Eligibility Criteria","preferredDefinition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._An operation in which a term denies or inverts the meaning of another term or construction._Earlier in time or order._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla._Having been established or verified._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2431097v1.0:5701688v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2431097","version":"1","preferredName":"Personal Medical History","preferredDefinition":"an account of all medical events and problems a person has experienced.","longName":"C18772","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF61-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5701688","version":"1","preferredName":"Negation Prior Breast Carcinoma Confirmation Clinical Trial Eligibility Criteria","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Earlier in time or order.:A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.:Having been established or verified.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"5701688v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4CE00B-2F5C-5D93-E053-F662850AC659","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"ONEDATA","dateModified":"2017-03-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4CE00B-2F2A-5D93-E053-F662850AC659","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeDescription":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5676955","version":"2","preferredName":"Confirmation Status","preferredDefinition":"Having been established or verified._A condition or state at a particular time.","longName":"CONFSTAT","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"11","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unconfirmed","valueDescription":"Negation Confirmation","ValueMeaning":{"publicId":"5676956","version":"1","preferredName":"Negation Confirmation","longName":"5676956","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having been established or verified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49380D88-AB51-745A-E053-F662850AA135","latestVersionIndicator":"Yes","beginDate":"2017-02-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7BA8394-AE40-165A-E053-4EBD850AA952","beginDate":"2017-02-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"ONEDATA","dateModified":"2020-06-10","deletedIndicator":"No"},{"value":"Confirmed","valueDescription":"Confirmation","ValueMeaning":{"publicId":"3953314","version":"1","preferredName":"Confirmation","longName":"3953314","preferredDefinition":"Having been established or verified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB78BCAD-A874-C88B-E040-BB89AD4330B5","latestVersionIndicator":"Yes","beginDate":"2013-11-18","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-11-18","modifiedBy":"TSESU","dateModified":"2019-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7BA8394-AE4A-165A-E053-4EBD850AA952","beginDate":"2017-02-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"ONEDATA","dateModified":"2020-06-10","deletedIndicator":"No"},{"value":"N/A","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7BA8394-AE54-165A-E053-4EBD850AA952","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"ONEDATA","dateModified":"2020-06-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7329879","version":"1","preferredName":"Confirmation Status","preferredDefinition":"Having been established or verified.:A condition or state at a particular time.","longName":"C25458:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BA8394-AE19-165A-E053-4EBD850AA952","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"ONEDATA","dateModified":"2020-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BA8394-AE2A-165A-E053-4EBD850AA952","latestVersionIndicator":"Yes","beginDate":"2017-02-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeDescription":"6/10/20 tmt versioned to 2.0 for changes to Long and Short names.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patients must not have previo","type":"Preferred Question Text","description":"Patients must not have previous personal history of  breast cancer, including ductal carcinoma in situ.","url":null,"context":"ECOG-ACRIN"}],"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D47958-C7E4-5EAC-E053-4EBD850AC8BB","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeDescription":"6/11/20 CDE versioned for updated VD; tmt. 11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}